Media Resources
If you are a member of the media interested in speaking with BioReference about the COVID-19 pandemic, and our company’s test capabilities and response. Please use the links below to view resources and get in touch with us.
Collaborations and News Timeline
To help support patients, providers and organizations with COVID-19 testing, BioReference has collaborated with local and national organizations, employers, and government agencies to bring reliable and scalable test solutions that will allow for early treatment and appropriate management of the virus.
News Timeline
4/27
BioReference continues providing PCR molecular and rapid COVID-19 testing to Major League Soccer players, match officials, and Club and League employees as well as testing the New England Revolution Fans for COVID-19 at Gillette Stadium in Foxborough, MA.
Read the press release
4/1
BioReference announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball (MLB) season.
Read the press release
3/26
BioReference is currently testing students and staff from two of the five largest school districts in the nation and is prepared to rapidly expand COVID-19 school testing to other school districts across the country.
Read the press release
2/22
BioReference opened eight locations, in support the NY Forward Rapid Testing Program, offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing.
Read the press release
1/26
BioReference announced COVID-19 testing agreements for players and officials, as well as team and league staff for the 2020-2021 seasons for the National Basketball Association (NBA) and National Hockey League (NHL).
Read the press release
1/13
BioReference introduced Scarlet Health™, an in-home, fully integrated digital platform providing access to on-demand diagnostic services. Scarlet has been designed similarly to tools consumers use daily, in order to provide ease-of-use and ubiquitous conveniences.
Read the press release
1/04
BioReference announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of 0.47 percent.
Read the press release
12/31
BioReference announced they will be performing COVID-19 Buffalo Bills, 2020 AFC East Division Champions, fan testing for the AFC Divisional Wild Card playoff game as well as the second round playoff game at Bills Stadium in Orchard Park.
Read the press release
12/10
Auth0, the identity platform for application teams, announced that it is providing BioReference with end-to-end authentication for its patient portal, giving patients HIPAA compliant and secure, direct access to their lab results and medical data.
Read the press release
10/20
BioReference offers a multiplex test for flu and COVID-19 at the same time, using a single sample. This allows for more rapid diagnosis, conserves critical testing supplies, and provides surveillance for flu and COVID-19.
Read the press release
10/9
BioReference announced the beginning of its COVID-19 testing program, starting with New York City. Continuing a strategic collaboration with New York City, the Department of Health, New York City Health and Hospital Corporation (NYC Health + Hospitals), the Test & Trace Corp, and the Department of Education, BioReference is performing COVID-19 molecular testing for NYC schools throughout the 2020-2021 school year to help ensure a safer school environment.
Read the press release
9/2
Through a strategic collaboration with New York City and NYC Health + Hospitals, BioReference performed COVID-19 testing for NYC school principals, teachers and staff members.
Read the press release
7/20
Awarded commercial surge capacity testing for COVID-19 emergency response contract by Centers for Disease Control and Prevention (CDC).
Read the press release
7/13
Selected by the National Basketball Association, BioReference is providing the NBA with COVID-19 testing.
Read the press release
7/9
Selected by the Major League Soccer, BioReference is providing the MLS with COVID-19 testing.
Read the press release
7/1
Reported results of COVID-19 testing for almost one quarter of a million nursing home and live-in facility employees.
Read the press release
5/18
Collaborated with New York Metropolitan Transportation Authority (MTA) and Northwell Health to offer MTA essential employees access to antibody testing.
Read the press release
5/15
Collaborated with MagnaCare to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area.
Read the press release
5/13
Launched Employer Solution, a COVID-19 screening program that assists employers’ decisions about return-to-work policies.
Read the press release
5/8
Collaborated with NYC Health + Hospitals to expand access to COVID-19 antibody testing.
Read the press release
5/7
Collaborated with NYC Mayor Bill de Blasio to expand antibody testing access to New Yorkers at community testing sites in the five boroughs.
Read the NYC press release
5/7
Selected by Rite Aid to provide COVID-19 laboratory testing to all drive-up locations with the goal of flattening the curve through accessible diagnostic testing.
Read the Rite Aid press release
4/29
Collaborated with NY state to test transit workers for antibodies to further determine the spread of infections among our frontline workers.
Read the Governor’s Office statement here
4/29
Launched nationwide availability of antibody blood tests to detect an immune response after infection with the COVID-19 virus.
Read the press release here
4/28
Selected by Rite Aid to provide COVID-19 laboratory testing to all drive-up locations with the goal of flattening the curve through accessible diagnostic testing.
Read the press release here
4/20
Expanded Lab Testing Capacity by leveraging Gaithersburg, Maryland GeneDx Lab, as well as Melbourne, Florida facility.
Read the press release here
4/6
Announced continued prioritization of COVID-19 testing for hospital inpatients and critically ill patients around the country, with almost 200,000 patients tested to date.
Read the press release here
3/24
Collaborated with the City of Miami to provide COVID-19 testing for Miami residents by appointment, and collaborated with Larkin Community Hospital to offer drive-through specimen collection centers in South Florida, Hialeah and Hollywood, FL.
Read the press release here
3/23
Collaborated with the City of Detroit to provide COVID-19 testing at drive-through locations for residents by appointment.
Read the press release here
3/20
Collaborated with the State of New Jersey to provide COVID-19 testing across the state, including access at the first five NJ drive-through testing facilities in the counties of Burlington, Essex, Hudson, Ocean and Union.
Read the press release here
3/20
Joined the New Jersey Governor Phil Murphy at a press conference in Bergen County to discuss COVID-19 testing and state operated drive-through testing sites.
Watch the press conference here
3/17
Collaborated with the New York City Health and Hospital Corporation (NYC Health + Hospitals) to provide coronavirus disease 2019 (COVID-19) testing to patients within the more than 70 care locations across the city’s five boroughs.
Read the press release here
3/17
Joined NYC Mayor de Blasio during New York City Hall press conference to discuss expanded testing throughput in support of the NYC public health system, highlighting how the private sector can assist with government agencies to help combat this epidemic.
Watch the press conference here
3/13
Collaborated with the New York State Department of Health and Governor Andrew M. Cuomo to provide testing for the first public drive-through testing facility on the East Coast, located in New Rochelle, NY, the epicenter for the New York State outbreak. Additional satellite testing sites to be set-up in the coming weeks.
Read the Governor’s Office statement here
3/13
Launched nationwide availability of a Real-Time Reverse Transcription Polymerase Chain Reaction (Real-Time RT-PCR) assay to aid healthcare providers in quickly and efficiently diagnosing patients.
Read the press release here
3/4
Attended a meeting with Vice President Mike Pence, members of the White House’s Coronavirus Task Force, The American Clinical Laboratory Association (ACLA) and other diagnostic laboratory leaders from across the nation to discuss the critical issues related to coronavirus disease testing capacity as the demand for testing in America grows.
Read the ACLA statement here
We continue to closely monitor and respond to this rapidly evolving situation. Please continue to visit this page for the most up-to-date information.